Nucleus Network
Nucleus Network
Melbourne, Victoria, Australia13 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07641634 | |
| A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, infectious disease | Recruiting | Phase 1 | 2026-09-30 | NCT07029932 | |
| A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt Disease 1, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2026-09-23 | NCT07836452 | |
| A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants | Healthy Participants | Recruiting | Phase 1 | 2026-09-15 | NCT06655870 | |
| Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT07317544 | |
| Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN101099 in Healthy Adult Participants | Healthy Adult | Recruiting | Phase 1 | 2026-08-21 | NCT07550946 | |
| A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria | Recruiting | Phase 1 | 2026-08-12 | NCT07446400 | |
| SAD Study of CGB3002 in Healthy Participants | Alzheimer s Disease | Recruiting | Phase 1 | 2026-07-08 | NCT07660341 | |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults. | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Iron Deficiencies, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, anemia, chronic renal failure syndrome, hematologic disorder, iron metabolism disease, kidney disorder, kidney failure, metabolic disease, urinary system disorder | Recruiting | Early phase 1 | 2026-06-12 | NCT07577817 | |
| Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 1 | 2026-06-09 | NCT06989840 | |
| A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 | 2026-05-05 | NCT06965751 | |
| A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorder | Recruiting | Phase 1 / Phase 2 | 2025-05-18 | NCT06874010 | |
| A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants | Healthy | Active, not recruiting | Phase 1 | 2025-03-26 | NCT06006702 |